Rank #1888DAWN

Day One Biopharmaceuticals, Inc

$12.07

4.41% (Daily)

Market Cap

$1.24B

Revenue

$133.67M

Rank by MCap

#1888

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Jeremy Bender M.B.A., Ph.D.

Headquarters

Brisbane, CA

Employees

184

About Day One Biopharmaceuticals, Inc

Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial st...